Product and variants
NAD+
500 mg · 1000 mg
Variant-linked analytical facts transcribed from the original COA PDF files. This page applies only to the batch and variants named below.
Reported 29 Jul 2026 · Received 23 Jul 2026 · Record verified 29 Sep 2026
NAD+
500 mg · 1000 mg
99.66% · RP-HPLC (260 nm)
ESI-MS · Conforms
Each link below is kept beside the exact variant named in the source record.
Chromatographic purity and mass-spectrometry identity answer different analytical questions. These results do not alone establish sterility, endotoxin status, fill quantity, stability, protocol suitability, or safety for human or animal use.
Published PDFs are supplier or manufacturer documentation. They are not presented as independent or accredited laboratory reports unless the PDF itself identifies the testing laboratory and accreditation.
— Batch, dates, purity and methods verified against the PDF currently published at each linked URL.